Starling Oncology, Inc. (STLNW) Capital expenditures 2020–2025
Starling Oncology, Inc. (STLNW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3.2MFY2025 · since FY2020: $1.2M → $3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2M | -15.5% |
| FY2024 | $3.8M | -17.0% |
| FY2023 | $4.6M | -17.4% |
| FY2022 | $5.5M | +94.2% |
| FY2021 | $2.8M | +138.4% |
| FY2020 | $1.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice